Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011

Clinical Research in Cardiology

Volumn 100, Issue 6, 2011, Pages 475-482

  Walenta, K ^a   Sinning, J M ^b   Werner, N ^b   Bohm M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

AFClinic; Everest II; ISAR CABG; Magellan; Partner A; Partner B; Platinum; Precombat; Resolute US; Rival; Stich; Stich viability

Indexed keywords

ENOXAPARIN; EVEROLIMUS; RAPAMYCIN; RIVAROXABAN; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ANGIOPLASTY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BARE METAL STENT; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONSENSUS DEVELOPMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG ELUTING STENT; FALSE ANEURYSM; FOLLOW UP; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LIVER DISEASE; LUNG EMBOLISM; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MULTICENTER STUDY (TOPIC); OPEN HEART SURGERY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAPHENOUS VEIN GRAFT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HUMANS; REGISTRIES; SOCIETIES, MEDICAL; UNITED STATES;

EID: 80051672670     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0322-3     Document Type: Article

References (18)

1. Gensch C, Hoppe U, Böhm M, Laufs U (2011) Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010. Clin Res Cardiol 100:1-9
2. Lenski M, Mahfoud F, Werner C, Bauer A, Böhm M (2010) Hotline sessions and clinical trial updates presented at the European Society of Cardiology Congress in Stockholm. Clin Res Cardiol 99:679-692
3. Figulla L, Neumann A, Figulla HR, Kahlert P, Erbel R, Neumann T (2011) Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol 100:265-276
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D (2010) Pocock S; PARTNER Trial Investigators. Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-1607
5. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. doi:10.1056/NEJMoa1100452
6. Feldman T, Foster E, Glower DG et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. doi: 10.1056/NEJMoa1009355
7. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; the STICH Investigators (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. doi:10.1056/ NEJMoa1100356
8. Maier L, Baumhäkel M, Böhm M (2009) Hotline sessions presented at the American College of Cardiology Congress 2009. Clin Res Cardiol 98:345-352
9. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza AJ; the STICH Trial Investigators (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. doi:10.1056/NEJMoa1100358
10. Mehili J (2011) Randomized, superiority trial of drug-eluting stent and bare metal stent in saphenous vein graft lesions. In: American College of Cardiology Scientific Sessions/i2 Summit SCAI annual meeting. Late breaking clinical trials. New Orleans, 2-5 April
11. Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; for the RIVAL trial group (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. doi:10.1016/S0140-6736(11)60404-2
12. Alan CY, Martin BL, Ash J, Thaddeus RT, Douglas JS, Brent TM, Jeffrey JP, Peter JF, Donald EC, Joseph MM, Laura M, RESOLUTE US Investigators (2011) Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries. The RESOLUTE US Clinical Trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2011.03.005
13. Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD, PLATINUM Trial Investigators (2011) A prospective, randomized evaluation of a novel everolimus-eluting coronary stent The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the treatment of up to two de novo coronary artery lesions) Trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2011.02.016
14. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M (2007) VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756-764 (Pubitemid 47555066)
15. Leizorovicz A, Mismetti P (2004) Preventing venous thromboembolism in medical patients. Circulation 110:IV13-IV19 (Pubitemid 40018731)
16. Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94:750-759 (Pubitemid 41489233)
17. Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos A, Tapson V (2011) Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis. doi:10.1007/s11239-011-0549-x
18. Hendricks JML (2011) Specialised atrial fibrillation clinic reduces cardiovascular morbidity and mortality in patients with atrial fibrillation. In: American College of Cardiology Scientific Sessions/i2 Summit SCAI annual meeting. Late breaking clinicaltrials. New Orleans 2-5 April